Oral AHR Antagonist in Combination With Nivolumab in Patients With PD-1 Resistant Metastatic or Recurrent Head and Neck Cancer

Clinical trial NCT05472506 · WITHDRAWN

Trial details

NCT number: NCT05472506
Sponsor: Ikena Oncology
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma Head and Neck Cancer Head Cancer Neck Cancer Head Cancer Neck Neck Carcinoma

Start date: 2023-03-01
Primary completion: 2023-04-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.